Market Overview:
The global Wilson's disease drugs market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of Wilson's disease, rising awareness about the availability of treatment options for Wilson's disease, and growing investments by key players in research and development (R&D) activities. The global Wilson's disease drugs market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into hepatic, neuropsychiatric, ophthalmic, and others. The hepatic segment accounted for a major share of the global Wilson's disease drugs market in 2017 owing to high prevalence rates for this type ofWilson'sdisease across regions.
Product Definition:
Wilson's disease is a rare genetic disorder that causes copper to accumulate in the liver, brain, and other organs. Wilson's disease drugs are used to treat this condition by reducing the amount of copper in the body.
Hepatic:
Hepatic is the part of the immune system that protects us from germs and harmful bacteria. In Wilson's disease, there is a problem with the way liver cells process copper. This leads to too much copper getting into body fluids (such as urine, sweat, blood), causing serious health problems.
The most common symptoms are fatigue, anorexia or weight loss, abdominal pain and constipation or diarrhea.
Neuropsychiatric:
Neuropsychiatric is the branch of medical science that studies brain and its functions, psychiatric disorders & behavior, and nervous system. Neuropsychiatric diseases are those which occur as a result of disease in the Central Nervous System (CNS). The term neuro-psycho refers to mental processes associated with brain such as perception, memory, intelligence, emotions etc.
Application Insights:
The others segment held the largest share of the global market in 2017. This segment includes injectables, ophthalmic drugs and oral medicines. Oral medicines include tablets, capsules and liquids that are taken by mouth for the treatment of Wilson¢â‚¬â„¢s disease. The injectable drugs comprise hydromorphone, dextrose and insulin for diabetes management which is a major factor contributing to their large share in this segment.
The hospital application segment is expected to witness lucrative growth over the forecast period due to increasing prevalence rates coupled with rising healthcare expenditure globally as well as locally across countries such as India, China Japan etc., where most of these hospitals do not have enough capacity or resources required for diagnosis & treatment leading towards longer stay at hospitals resulting in high demand for various diagnostic & therapeutic procedures thereby driving this industry further during future years.
Regional Analysis:
North America dominated the global Wilson's disease drugs market in 2017. The presence of key players, favorable reimbursement policies, and increasing prevalence ofWilson's disease are some factors responsible for its large share. In addition, growing awareness about the condition and rising healthcare expenditure in this region also contribute to its large revenue share.
The U.S., which is at the forefront of North America with a revenue share of over 80%, is one of the most affected countries worldwide by Wilson's disease owing to high population density along with rapid urbanization and industrialization that have resulted in environmental pollution leading to increased incidence ratesofWilson's disease across this region as well as globally (CDC).
Growth Factors:
- Increasing prevalence of Wilson's disease
- Growing awareness about Wilson's disease among people
- Rising demand for better and effective drugs for the treatment of Wilson's disease
- Technological advancements in the field of drug development for Wilson's disease
- Availability of government funding and support for research onWilson's Disease
Scope Of The Report
Report Attributes
Report Details
Report Title
Wilson's Disease Drugs Market Research Report
By Type
Hepatic, Neuropsychiatric, Ophthalmic, Others
By Application
Hospitals, Clinic, Others
By Companies
Kadmon Holdings, Inc., Merck & Co., Teva Pharmaceutical Industries Limited, Tsumura & Co., Valeant Pharmaceuticals International, Inc., VHB Life Sciences, Inc., Wilson Therapeutics AB (Alexion)
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
223
Number of Tables & Figures
157
Customization Available
Yes, the report can be customized as per your need.
Global Wilson's Disease Drugs Market Report Segments:
The global Wilson's Disease Drugs market is segmented on the basis of:
Types
Hepatic, Neuropsychiatric, Ophthalmic, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinic, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Kadmon Holdings, Inc.
- Merck & Co.
- Teva Pharmaceutical Industries Limited
- Tsumura & Co.
- Valeant Pharmaceuticals International, Inc.
- VHB Life Sciences, Inc.
- Wilson Therapeutics AB (Alexion)
Highlights of The Wilson's Disease Drugs Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Hepatic
- Neuropsychiatric
- Ophthalmic
- Others
- By Application:
- Hospitals
- Clinic
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Wilson's Disease Drugs Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Wilson's disease drugs are medications used to treat Wilson's disease. These medications help to reduce the amount of copper in the body, which can lead to health problems.
Some of the key players operating in the wilson's disease drugs market are Kadmon Holdings, Inc., Merck & Co., Teva Pharmaceutical Industries Limited, Tsumura & Co., Valeant Pharmaceuticals International, Inc., VHB Life Sciences, Inc., Wilson Therapeutics AB (Alexion).
The wilson's disease drugs market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Wilson's Disease Drugs Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Wilson's Disease Drugs Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Wilson's Disease Drugs Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Wilson's Disease Drugs Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Wilson's Disease Drugs Market Size & Forecast, 2018-2028
4.5.1 Wilson's Disease Drugs Market Size and Y-o-Y Growth
4.5.2 Wilson's Disease Drugs Market Absolute $ Opportunity
Chapter 5 Global Wilson's Disease Drugs Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Wilson's Disease Drugs Market Size Forecast by Type
5.2.1 Hepatic
5.2.2 Neuropsychiatric
5.2.3 Ophthalmic
5.2.4 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Wilson's Disease Drugs Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Wilson's Disease Drugs Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinic
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Wilson's Disease Drugs Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Wilson's Disease Drugs Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Wilson's Disease Drugs Analysis and Forecast
9.1 Introduction
9.2 North America Wilson's Disease Drugs Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Wilson's Disease Drugs Market Size Forecast by Type
9.6.1 Hepatic
9.6.2 Neuropsychiatric
9.6.3 Ophthalmic
9.6.4 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Wilson's Disease Drugs Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinic
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Wilson's Disease Drugs Analysis and Forecast
10.1 Introduction
10.2 Europe Wilson's Disease Drugs Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Wilson's Disease Drugs Market Size Forecast by Type
10.6.1 Hepatic
10.6.2 Neuropsychiatric
10.6.3 Ophthalmic
10.6.4 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Wilson's Disease Drugs Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinic
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Wilson's Disease Drugs Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Wilson's Disease Drugs Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Wilson's Disease Drugs Market Size Forecast by Type
11.6.1 Hepatic
11.6.2 Neuropsychiatric
11.6.3 Ophthalmic
11.6.4 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Wilson's Disease Drugs Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinic
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Wilson's Disease Drugs Analysis and Forecast
12.1 Introduction
12.2 Latin America Wilson's Disease Drugs Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Wilson's Disease Drugs Market Size Forecast by Type
12.6.1 Hepatic
12.6.2 Neuropsychiatric
12.6.3 Ophthalmic
12.6.4 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Wilson's Disease Drugs Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinic
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Wilson's Disease Drugs Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Wilson's Disease Drugs Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Wilson's Disease Drugs Market Size Forecast by Type
13.6.1 Hepatic
13.6.2 Neuropsychiatric
13.6.3 Ophthalmic
13.6.4 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Wilson's Disease Drugs Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinic
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Wilson's Disease Drugs Market: Competitive Dashboard
14.2 Global Wilson's Disease Drugs Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Kadmon Holdings, Inc.
14.3.2 Merck & Co.
14.3.3 Teva Pharmaceutical Industries Limited
14.3.4 Tsumura & Co.
14.3.5 Valeant Pharmaceuticals International, Inc.
14.3.6 VHB Life Sciences, Inc.
14.3.7 Wilson Therapeutics AB (Alexion)
